Clinical trials
Phase 4 Cardiovascular Diseases trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 46 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hamilton Health Sciences Corporation | 2 |
| Augusta University | 1 |
| Azienda Policlinico Umberto I | 1 |
| Brigham and Women's Hospital | 1 |
| Canadian Medical and Surgical Knowledge Translation Research Group | 1 |
| China National Center for Cardiovascular Diseases | 1 |
| Federal University of Pelotas | 1 |
| Fudan University | 1 |
| Guangzhou General Hospital of Guangzhou Military Command | 1 |
| Hanna Savolainen-Peltonen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 46 |
| Atherosclerosis | 8 |
| Diabetes Mellitus, Type 2 | 6 |
| Dyslipidemias | 6 |
| Coronary Artery Disease | 5 |
| Coronary Disease | 4 |
| Diabetes Mellitus | 4 |
| Hypertension | 4 |
| Myocardial Infarction | 4 |
| Heart Diseases | 3 |
Trials
Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.